# US 2014/0236073 A1 · Nitric oxide therapies

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0236073 A1
- Document ID: US20140236073A1
- Status: Published application
- Kind: A1
- Application number: 14/138,061
- Filed: 2013-12-21
- Published: 2014-08-21
- Earliest claimed: 2009-06-22
- Assignees: Geno LLC
- Applicants: Geno LLC
- Inventors: David H. Fine
- Web page: https://patentgrep.com/patent/US20140236073A1

## CPC

- A61M 16/12: by mixing different gases
- A61K 31/655: Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 47/02: Inorganic compounds
- A61M 5/165: Filtering accessories, e.g. blood filters, filters for infusion liquids (A61M1/34, A61M5/36 take precedence)
- A61M 15/00: Inhalators {(drug delivery in endotracheal tubes A61M16/04)}
- A61M 15/08: Inhaling devices inserted into the nose
- A61M 15/085: {Fixing means therefor}
- A61M 16/105: {Filters (A61M16/047, A61M16/22 take precedence; water traps A61M16/08)}
- A61M 35/006: {using sponges, foams, absorbent pads or swabs as spreading means}
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 9/0043: {Nose}
- A61K 9/0073: {Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; (nasal sprays A61K9/0043; inhalation of vapours of volatile or heated drugs, e.g. essential oils or nicotine, A61K9/007; devices A61M)}
- A61K 9/7023: {Transdermal patches and similar drug-containing composite devices, e.g. cataplasms (galenical aspects of iontophoretic devices A61K9/0009; microneedle arrays A61K9/0021; buccal patches A61K9/006)}
- A61M 2005/006: {for gases, e.g. CO2}
- A61M 2202/0275: Nitric oxide [NO]
- A61M 2205/75: with filters
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition.

## Claims

### Claim at position 1

-21. (canceled)

### Claim 22

A nitric oxide delivery device comprising:
an inlet,
an outlet,
a particle filter at the outlet,
a chamber, and
a composition within the chamber including a nitric-oxide releasing agent, silica, and an antioxidant.

### Claim 23 (depends on 22)

The nitric oxide delivery device of claim 22, wherein the nitric-oxide releasing agent is polymeric composition including a polymer and at least one nitric oxide releasing N2O2-functional group.

### Claim 24 (depends on 22)

The nitric oxide delivery device of claim 22, wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

### Claim 25 (depends on 22)

The nitric oxide delivery device of claim 22, wherein the nitric oxide agent is selected from the group consisting of X[N(O)NO] and [N(O)NO]X.

### Claim 26 (depends on 22)

The nitric oxide delivery device of claim 22, wherein the composition further includes water.

### Claim 27 (depends on 22)

The nitric oxide delivery device of claim 22, wherein the particle filter includes two concentric annular filters with a surface-active material located between the two annular filters.

### Claim 28 (depends on 27)

The nitric oxide delivery device of claim 27, wherein surface-active material is silica gel.

### Claim 29 (depends on 22)

The nitric oxide delivery device of claim 22, wherein the inlet, outlet and chamber each have a width, wherein the width is measured in a direction perpendicular to the longitudinal axis of the delivery device, and the width of the chamber is greater than the width of the inlet or outlet.

### Claim 30 (depends on 22)

The nitric oxide delivery device of claim 22, wherein the inlet, outlet and chamber are cylindrical, and the diameter of the chamber is greater than the diameter of the inlet or the diameter of the outlet.
